Skip to content
TrustList
Newave Capital logo
Investor

Newave Capital

Venture studio helping blockchain teams enter the Chinese market with marketing, community and investor links

Newave Capital cover

About Newave Capital

Newave Capital is a venture studio that helps blockchain projects from overseas open the Chinese market. It combines data analytics, market research, process improvement and international partnerships to support teams from launch until adoption takes off. It favours founders who show results and challenge the status quo.

What Newave Capital offers

  • China venture connections — introduces teams to investors in China.
  • Community management — builds and looks after project communities.
  • Marketing and public relations — uses a large network of communities and blockchain media partners.
  • Exchange listing help — supports getting listed on exchange platforms.
  • End-to-end support — guides partners through the growth stage to maturity.

Who it works with

Blockchain teams from abroad that need to localise their projects for China and its counterparts.

Profile written by TrustList from the business's own published information, Oct 2026.

Ask TrustList to introduce you to Newave Capital

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA — Google Privacy Policy and Terms apply.

Reviews

Write the first review of Newave Capital

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Newave Capital.

Newave Capital alternatives

Similar listings buyers compare against this one.

Desktop office software with a word processor, spreadsheet, presentations and PDF tools for individuals

Semiconductor and display equipment maker that also invests in startups through venture and research programmes

Medical device manufacturer making implants and therapies for heart, cancer and spinal conditions

Innovation platform running accelerator programmes and startup investments that link corporations with young technology companies

San Francisco early-stage technology venture firm led by two founding partners with a stated humane-technology outlook